Avricore Health (AVCRF) Receivables - Other (2010 - 2024)

Avricore Health has disclosed Receivables - Other across 7 years of filings, most recently posting $3811.2 for Q4 2024.

• In Q4 2024, Receivables - Other fell 22.45% year-over-year to $3811.2; the TTM figure through Dec 2024 stood at $3811.2 (down 22.45% YoY), while the FY2024 annual figure was $3888.6, down 21.59% from the prior year.
• Receivables - Other declined to $3811.2 in Q4 2024, from $4914.8 in the prior quarter.
• Over the last five years, Receivables - Other for AVCRF reached as high as $16410.8 in Q4 2022 and fell as low as $1632.3 in Q4 2020.
• The 5-year median for Receivables - Other is $4914.8 (2023), against an average of $6575.7.
• Annual changes were most pronounced in 2021 — Receivables - Other soared 274.29% — and 2023, when it slumped 70.05%.
• A 5-year view of Receivables - Other shows it stood at $1632.3 in 2020, then soared by 274.29% to $6109.5 in 2021, then jumped by 168.61% to $16410.8 in 2022, then tumbled by 70.05% to $4914.8 in 2023, then decreased by 22.45% to $3811.2 in 2024.
• According to Business Quant data, Receivables - Other over the past three periods registered $3811.2, $4914.8, and $16410.8 for Q4 2024, Q4 2023, and Q4 2022 respectively.